PMC:7228307 / 30745-30967
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"536","span":{"begin":104,"end":115},"obj":"Chemical"},{"id":"537","span":{"begin":45,"end":50},"obj":"Disease"}],"attributes":[{"id":"A536","pred":"tao:has_database_id","subj":"536","obj":"MESH:C556306"},{"id":"A537","pred":"tao:has_database_id","subj":"537","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T306","span":{"begin":63,"end":67},"obj":"Body_part"},{"id":"T307","span":{"begin":179,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A306","pred":"fma_id","subj":"T306","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A307","pred":"fma_id","subj":"T307","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T54","span":{"begin":97,"end":100},"obj":"Disease"}],"attributes":[{"id":"A54","pred":"mondo_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/MONDO_0016702"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T598","span":{"begin":54,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T599","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T600","span":{"begin":179,"end":184},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T186","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/CL_0000000"},{"id":"T187","span":{"begin":179,"end":184},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"536","span":{"begin":104,"end":115},"obj":"Chemical"},{"id":"537","span":{"begin":45,"end":50},"obj":"Disease"}],"attributes":[{"id":"A536","pred":"pubann:denotes","subj":"536","obj":"MESH:C556306"},{"id":"A537","pred":"pubann:denotes","subj":"537","obj":"MESH:D003643"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T172","span":{"begin":0,"end":222},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T338","span":{"begin":203,"end":207},"obj":"Protein"}],"attributes":[{"id":"A338","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q9BYU0"},{"id":"A339","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q99NE3"},{"id":"A340","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q99NE2"},{"id":"A341","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q99NE1"},{"id":"A342","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q99NE0"},{"id":"A343","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q8SQ34"},{"id":"A344","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q8K2X6"},{"id":"A345","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q86YK5"},{"id":"A346","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q7YRL5"},{"id":"A347","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q7M4Q8"},{"id":"A348","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q5U007"},{"id":"A349","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q5JY15"},{"id":"A350","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q542B1"},{"id":"A351","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q53GN5"},{"id":"A352","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q3ZTK5"},{"id":"A353","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q3UBH3"},{"id":"A354","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q3U7C9"},{"id":"A355","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q3U799"},{"id":"A356","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q3TSL2"},{"id":"A357","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q3TS33"},{"id":"A358","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q3LRP1"},{"id":"A359","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/Q28203"},{"id":"A360","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/P27512"},{"id":"A361","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/P25942"},{"id":"A362","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/E1P5S9"},{"id":"A363","pred":"uniprot_id","subj":"T338","obj":"https://www.uniprot.org/uniprot/A7YWS9"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-sample-PD-FMA
{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T305","span":{"begin":63,"end":67},"obj":"Body_part"},{"id":"T306","span":{"begin":179,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A305","pred":"fma_id","subj":"T305","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A306","pred":"fma_id","subj":"T306","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-sample-PD-GO-BP-0
{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T89","span":{"begin":45,"end":50},"obj":"http://purl.obolibrary.org/obo/GO_0016265"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T172","span":{"begin":0,"end":222},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Such examples are the induction of apoptotic death in a target cell, which is likely part of the MOA of daratumumab in multiple myeloma60 or the controlled agonistic expansion of cells, for example, via CD40 mAb agonism.43"}